Unknown

Dataset Information

AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.


ABSTRACT:

Objective

Type 1 diabetes is characterized by autoimmune destruction of β-cells leading to severe insulin deficiency. Although many improvements have been made in recent years, exogenous insulin therapy is still imperfect; new therapeutic approaches, focusing on preserving/expanding β-cell mass and/or blocking the autoimmune process that destroys islets, should be developed. The main objective of this work was to test in non-obese diabetic (NOD) mice, which spontaneously develop autoimmune diabetes, the effects of local expression of Insulin-like growth factor 1 (IGF1), a potent mitogenic and pro-survival factor for β-cells with immunomodulatory properties.

Methods

Transgenic NOD mice overexpressing IGF1 specifically in β-cells (NOD-IGF1) were generated and phenotyped. In ad

SUBMITTER: Mallol C 

PROVIDER: S-EPMC5485311 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature